Omega-3 fatty acids: antiarrhythmic, proarrhythmic or both?

Area of Science:

• Cardiology
• Nutritional Science
• Pharmacology

Background:

• Recent studies question the cardiac safety of marine omega-3 fatty acids EPA and DHA.
• Concerns exist regarding potential pro-arrhythmic effects of these essential fatty acids.

Purpose of the Study:

• To review and contextualize recent findings on the effects of EPA and DHA on cardiac rhythm.
• To evaluate the evidence for both pro-arrhythmic and antiarrhythmic mechanisms of omega-3 fatty acids.

Main Methods:

• Review of in-vitro, animal model, and human intervention studies.
• Analysis of systematic reviews on omega-3 fatty acid supplementation and cardiac events.
• Comparison of omega-3 index levels and sudden cardiac death rates across populations.

Main Results:

• In vitro and animal studies show more antiarrhythmic than pro-arrhythmic effects of omega-3s.
• EPA and DHA supplementation reduced new-onset atrial fibrillation post-coronary bypass grafting.
• Systematic reviews indicate EPA and DHA reduce sudden cardiac death by 50%.
• A low omega-3 index is associated with increased risk of sudden cardiac death, while high levels (e.g., in Japan) correlate with lower incidence.

Conclusions:

• Concerns regarding pro-arrhythmic effects of EPA and DHA are largely theoretical.
• The evidence strongly supports an antiarrhythmic role for omega-3 fatty acids, particularly when considering the omega-3 index.
• The omega-3 index is a valuable tool for assessing EPA and DHA status and monitoring therapy.